Verve Therapeutics (VERV) Stock Chart & Stock Price History → Man who Predicted Trump 2016 Win: “Prepare for Election Meltdown” (From Paradigm Press) (Ad) Free verv Stock Alerts $5.42 -0.18 (-3.21%) (As of 06/14/2024 ET) Add Compare Share Share ChartStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrendsStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrends Verve Therapeutics Stock Price Performance5 Day Performance+1.12%1 Month Performance-13.00%3 Month Performance-60.75%6 Month Performance-60.89%Year-To-Date Performance-61.12%1 Year Performance-72.68% Receive VERV Stock News and Ratings via Email Sign-up to receive the latest news and ratings for Verve Therapeutics and its competitors with MarketBeat's FREE daily newsletter Email Address Ad Paradigm PressMan who Predicted Trump 2016 Win: “Prepare for Election Meltdown”Former advisor to the CIA, the Pentagon and the White House Jim Rickards went on multiple TV news programs… A predicted Trump would win. You won’t believe what he’s predicting now.Click here to see it because it’s a SHOCKER… VERV Stock Chart for Saturday, June, 15, 2024 VERV Chart by TradingView Verve Therapeutics Share Price History Daily Weekly Monthly Time Frame Custom Range 1 Month 3 Months 6 Months Year-to-Date 1 Year Time Frame * Start Date * End Date Export to Excel DateOpening PriceClosing PriceHighLowVolumeMarket Capitalization06/14/2024$5.60$5.42-3.21%$5.76$5.36947,467 shs$455.06 million06/13/2024$5.59$5.60+0.18%$5.75$5.50969,422 shs$470.18 million06/12/2024$5.33$5.59+4.88%$5.79$5.501.24 million shs$469.34 million06/11/2024$5.36$5.33-0.56%$5.43$5.131.23 million shs$447.51 million06/10/2024$5.21$5.36+2.88%$5.37$4.961.26 million shs$450.03 million06/07/2024$5.28$5.21-1.33%$5.30$5.10709,681 shs$437.43 million Get the Latest News and Ratings for VERV and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Verve Therapeutics and its competitors with MarketBeat's FREE daily newsletter. 06/06/2024$5.34$5.28-1.12%$5.37$5.20959,819 shs$443.31 million06/05/2024$5.29$5.34+0.95%$5.35$5.151.20 million shs$448.37 million06/04/2024$5.25$5.29+0.76%$5.47$5.141.11 million shs$444.15 million06/03/2024$5.19$5.25+1.16%$5.59$5.161.61 million shs$440.79 million05/31/2024$5.14$5.19+0.97%$5.26$5.081.55 million shs$431.58 million05/30/2024$5.08$5.14+1.18%$5.32$4.971.58 million shs$431.55 million05/29/2024$5.24$5.08-3.05%$5.14$4.901.84 million shs$426.52 million05/28/2024$5.28$5.24-0.76%$5.49$5.171.27 million shs$439.95 million05/27/2024$5.28$5.28$5.43$5.23934,400 shs$443.31 million05/24/2024$5.33$5.28-0.94%$5.43$5.23931,666 shs$443.31 million05/23/2024$5.60$5.33-4.82%$5.64$5.261.43 million shs$447.51 million05/22/2024$5.54$5.60+1.08%$5.74$5.381.93 million shs$470.18 million05/21/2024$5.95$5.54-6.89%$6.00$5.521.48 million shs$465.17 million05/20/2024$5.98$5.95-0.50%$6.08$5.661.54 million shs$499.56 million05/17/2024$6.38$5.98-6.27%$6.34$5.902.19 million shs$502.08 million05/16/2024$6.23$6.38+2.41%$6.77$6.322.14 million shs$535.67 million05/15/2024$6.23$6.23$6.62$6.121.22 million shs$523.07 million05/14/2024$6.22$6.23+0.16%$6.83$6.131.49 million shs$523.07 million05/13/2024$6.01$6.22+3.49%$6.83$6.101.71 million shs$522.23 million05/10/2024$6.36$6.01-5.50%$6.43$5.881.60 million shs$504.36 million05/09/2024$6.08$6.36+4.61%$6.73$6.131.96 million shs$533.73 million05/08/2024$6.16$6.08-1.30%$6.29$5.991.46 million shs$510.23 million05/07/2024$6.41$6.16-3.90%$6.46$6.05886,791 shs$516.95 million05/06/2024$6.41$6.41$6.73$6.28811,985 shs$537.95 million05/03/2024$6.15$6.41+4.23%$7.00$6.281.39 million shs$537.93 million05/02/2024$6.00$6.15+2.50%$6.25$6.00949,350 shs$516.11 million05/01/2024$6.01$6.00-0.17%$6.56$5.841.76 million shs$504.38 million04/30/2024$6.26$6.01-3.99%$6.31$5.961.02 million shs$502.56 million04/29/2024$6.16$6.26+1.62%$6.54$6.11933,090 shs$523.46 million04/26/2024$6.22$6.16-0.96%$6.41$6.02791,349 shs$515.10 million04/25/2024$6.58$6.22-5.47%$6.35$6.051.22 million shs$520.12 million04/24/2024$6.88$6.58-4.36%$6.92$6.531.00 million shs$550.22 million04/23/2024$6.91$6.88-0.43%$7.41$6.81962,924 shs$575.31 million04/22/2024$6.64$6.91+4.07%$7.03$6.46909,064 shs$577.81 millionMan who Predicted Trump 2016 Win: “Prepare for Election Meltdown” (Ad)Former advisor to the CIA, the Pentagon and the White House Jim Rickards went on multiple TV news programs… A predicted Trump would win. You won’t believe what he’s predicting now.Click here to see it because it’s a SHOCKER…04/19/2024$6.66$6.64-0.30%$6.80$6.421.10 million shs$555.24 million04/18/2024$6.74$6.66-1.19%$6.85$6.531.25 million shs$556.91 million04/17/2024$7.14$6.74-5.60%$7.27$6.721.15 million shs$563.60 million04/16/2024$7.31$7.14-2.33%$7.26$7.04691,035 shs$597.05 million04/15/2024$7.60$7.31-3.82%$7.73$7.131.37 million shs$611.26 million04/12/2024$8.07$7.60-5.82%$8.02$7.541.19 million shs$635.51 million04/11/2024$8.01$8.07+0.75%$8.40$7.901.08 million shs$674.81 million04/10/2024$8.75$8.01-8.46%$8.32$7.761.72 million shs$669.80 million04/09/2024$8.40$8.75+4.17%$8.77$8.37872,383 shs$731.68 million04/08/2024$8.52$8.40-1.41%$8.75$8.241.03 million shs$702.40 million04/05/2024$8.68$8.52-1.84%$8.75$8.181.38 million shs$712.44 million04/04/2024$8.71$8.68-0.34%$9.23$8.641.63 million shs$725.81 million04/03/2024$8.32$8.71+4.69%$8.92$8.172.73 million shs$728.33 million04/02/2024$12.79$8.32-34.95%$9.28$7.3610.02 million shs$695.72 million04/01/2024$13.28$12.79-3.69%$13.24$12.52868,948 shs$1.07 billion03/29/2024$13.28$13.28$13.63$12.94647,690 shs$1.11 billion03/28/2024$13.19$13.28+0.68%$13.63$12.96647,590 shs$1.11 billion03/27/2024$12.79$13.19+3.13%$13.24$12.65633,369 shs$1.10 billion03/26/2024$13.16$12.79-2.81%$13.43$12.77663,883 shs$1.07 billion03/25/2024$12.97$13.16+1.46%$13.23$12.81524,538 shs$1.10 billion03/22/2024$13.21$12.97-1.82%$13.24$12.80584,615 shs$1.08 billion03/21/2024$13.38$13.21-1.27%$14.26$13.05888,884 shs$1.10 billion03/20/2024$13.01$13.38+2.84%$13.54$12.67780,762 shs$1.12 billion03/19/2024$13.31$13.01-2.25%$13.48$12.89870,559 shs$1.09 billion03/18/2024$13.81$13.31-3.62%$13.81$12.82878,195 shs$1.11 billion03/15/2024$13.60$13.81+1.54%$14.03$13.474.71 million shs$1.15 billion03/14/2024$14.34$13.60-5.16%$14.30$13.39971,086 shs$1.14 billion Related Companies: NewAmsterdam Pharma Stock Chart Keros Therapeutics Stock Chart Galapagos Stock Chart Gemini Therapeutics Stock Chart Evotec Stock Chart Harmony Biosciences Stock Chart Syndax Pharmaceuticals Stock Chart Kura Oncology Stock Chart Akero Therapeutics Stock Chart Taro Pharmaceutical Industries Stock Chart Receive VERV Stock News and Ratings via EmailSign-up to receive the latest news and ratings for Verve Therapeutics and its competitors with MarketBeat's FREE daily newsletter. This page (NASDAQ:VERV) was last updated on 6/15/2024 by MarketBeat.com Staff From Our PartnersThe #1 Crypto That You Don’t Own… YetThere’s all kinds of “signals” to follow when investing in cryptos. But there’s one signal you should pay a...Crypto 101 Media | SponsoredTop 5 Tech Stocks to Buy for 2024The next evolution of technology is already upending industries worth $7 Trillion… It's already got the world'...Daily Market Alerts | SponsoredTop 5 AI Stocks to Buy for 2024The electric vehicle boom is accelerating – and fast.Market Moving Trends | SponsoredHurry! Buy this stock before the Robinhood traders do!Robinhood traders have piled $78 billion into this market... Driving tiny tech stock gains of 3,000%, 8,942...Traders Agency | SponsoredAI's Next Magnificent SevenThe Original Magnificent Seven Produced 16,894% Average Returns Over 20 Years.The Oxford Club | SponsoredThe Only Energy Play You Should Be Looking AtOpen AI’s Sam Altman recently helped this company raise $577 million in funding… What’s more is, It has alr...Wealthpin Pro | SponsoredBill Clinton Backing Biden Replacement???Do you want to see who I believe will be the next president of the U.S.A? It won’t be Biden…And it won’t be...The Freeport Society | SponsoredBiden out June 13; replacement chosen?On November 16, 2023… Joe Biden accidentally revealed the name of the candidate… Who will replace him in...Paradigm Press | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Verve Therapeutics, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Verve Therapeutics With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.